期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

健择联合顺铂化疗对非小细胞肺癌患者外周血CD4^+CD25^+Foxp3^+调节T细胞的影响 被引量：12

Changes of the CD4^+CD25^+Foxp3^+ Treg Cells in Peripheral Blood in Patients with NSCLC with Gemzar and Cisplatin Regimen
下载PDF
导出
摘要 目的探讨健择联合顺铂对非小细胞肺癌患者免疫耐受的调控作用。方法38例经病理学或细胞学确诊的NSCLC患者,采用健择、顺铂联合化疗方案,应用流式细胞仪检测化疗前后外周血CD4+CD25+Foxp3+调节T细胞(Treg)占CD4+T细胞的百分率。结果化疗前NSCLC患者外周血CD4+CD25+Foxp3+调节T细胞(Treg)占CD4+T细胞的比率明显高于健康对照组(P<0.05);化疗后NSCLC患者外周血CD4+CD25+Foxp3+调节T细胞(Treg)占CD4+T细胞的百分率较化疗前显著降低(P<0.05);但鳞癌、腺癌及腺鳞癌3组间化疗前、化疗后各项指标之间差异无统计学意义(P>0.05)。结论健择联合顺铂化疗可调控晚期非小细胞肺癌机体的肿瘤免疫耐受,改善患者的免疫功能。 Objective To investgate the effect on immune function of patients with non-small cell lung cancer （NSCLC） treated with gemcitabine and cisplatin regimen. Methods The prevalence of CD4^＋ CD25^＋ Foxp3^＋ T regulatory（Treg） cells in peripheral blood in 38 patients with NSCLC , treated with gemcitabine plus cisplatin chemotherapy regimen, was detected by flow cytometry. Results The percentage of CD4^＋ CD25^＋ Foxp3 ^＋ Treg cells in peripheral blood of the patients with NSCLC pre-chemotherapy was significantly higher than that in healthy doners; compared with pre-chemotherapy , the percentage of CD4^＋ CD25 ^＋ Foxp3 ^＋ Treg cells in peripheral blood was significantly decreased in post-chemotherapy pa tients （P〈0. 05） ; there were no significant differences observed among squamous cell carcinoma, adenocarcinoma and adenosquamocarcinoma （P〉0.05）. Conclusion Gemcitabine plus cisplatin chemotherapy can improve the immune-tolerance in advanced non-small cell lung cancer patients.
作者 周娓 喻杰 刘莉 刘仲萍
机构地区 湖北省鄂州市中医院肿瘤科 华中科技大学附属协和医院肿瘤诊疗研究中心 华中科技大学附属协和医院干细胞中心
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第5期343-346,共4页 Cancer Research on Prevention and Treatment
关键词 CD4^+CD25^+FOXP3^+ 调节T细胞(Treg) 流式细胞术 化疗 CD4^＋CD25^＋Foxp3^＋ regulatorv T cell（Tree） Flow cvtometry Chemotherapy
分类号 R730.53 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Sakaguchi S, Sakaguchi N, Asano M, et al . Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor-chains (CD25):breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol , 1995 , 155(3) : 1151-1164.
  • 2刘莉,姚军霞,丁乾,曹如波,王晶,黄士昂.肿瘤患者中高表达人白细胞分化抗原25的调节T细胞检测及其临床意义[J].中华检验医学杂志,2006,29(4):304-306. 被引量：7
  • 3Zou W. Regulatory T cells, tumor immunity and immunotherapy (review)[J]. Nat Rev Immunol,2006,6(4): 295-307.
  • 4Gallimore A , Aguehi S. Regulation of tumor of immunity by CD25^+ T cells[J]. Immunology, 2002,107 ( 1 ) : 5-9.
  • 5Hori S , Nomura T ,Sakaguchi S ,et al. Control of regulatory T cell development by the transeription factor Foxp3 [J]. Seience, 2003,259(5609) : 1057-1061.
  • 6Fontenot J D,Gavin M A, Rudensky A Y, et al. Foxp3 Programs the development and function of CD4^+ CD25^+ regulatory T cells [J]. Nat Immunol,2003,4(4):330-336.
  • 7Liu Li, Yao Jun-xia, Ding Qian, et al. CD4^+CD25^high Regulatory Cellin Peripheral Blood of NSCLC[J]. Acta of Huazhong Uni of Sci and Technology [Med Sci], 2006,26(5):548- 550.
  • 8Diedrichsen AC , Hjelmborgi B , Christensen PB , et al. Prognostic value of t he CD4^+/ CD8^+ ratio of the tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells[J]. Cancer Immunol Immunother, 2003, 52 (7) :423-428.
  • 9Sutmuller RP, van Duivenvoorde LM, van Elsas A,et al . Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25 ( + ) regulatory T cells inantitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses[J]. J Exp Med, 2001,194(6) :823-832.
  • 10管忠震,陈茹琴,徐光川,李宇红,许立功,李龙云,刘叙仪,廖美琳,李金瀚.Gemcitabine治疗晚期非小细胞肺癌的临床研究[J].癌症,1999,18(3):241-245. 被引量：177

二级参考文献10

  • 1Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25)-Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol,1995,155:1151-1164.
  • 2Baecher-Allan C,Brown JA,Gordon GJ,et al.CD4+CD25high regulatory cells in human peripheral blood.J Immunol,2001,167:1245-1253.
  • 3Seo N,Hayakawa S,Takigawa M,et al.Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity.Immunology,2001,103:449-457.
  • 4Horwitz DA,Zheng SG,Gray JD.The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+CD25+ and CD8+ regulatory T cell subsets.J Leukoc Biol,2003,74:471-478.
  • 5Azuma T,Takahashi T,Kunisato A,et al.Human CD4+CD25+ regulatory T cells suppress NKT cell function.Cancer Res,2003,63:4516-4520.
  • 6Bopp T,Palmetshofer A,Serfling E,et al.NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells.J Exp Med,2005,201:181-187.
  • 7Baecher-Allan C,Brown JA,Freeman GJ,et al.CD4+ CD25+ Regulatory T cells from human peripheral blood express very high levels of CD25 ex vivo.Novaritis Found Symp,2003,252:67-88,88-91,106-114.
  • 8Sasada T,Kimura M,Yoshida Y,et al.CD4+ CD25+ regulatory T cells in patients with gastrointestinal malignancies:possible:possible involvement of regulatory T cells in disease progression.Cancer,2003,98:1089-1099.
  • 9Tanaka H,Tanaka J,Kjaergaard J,et al.Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes.J Immunother,2002,2:207-217.
  • 10Nagai H,Horikawa T,Hara I,et al.In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma,when combined with interleukin-12 gene transfer.Exp Dermatol,2004,13:613-620.

共引文献181

同被引文献214

引证文献12

二级引证文献83

肿瘤防治研究
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部